Colorectal cancer is the second-most-common cause of cancer fatalities in the United States, with 150,000 diagnoses annually and 52,000 deaths; only lung cancer kills more. It has grabbed headlines...

YouTube video by The Ruesch Center

In an interview with Peers & Perspectives in Oncology, John L. Marshall, MD, discussed treatment approaches and sequencing for refractory colorectal cancer.

Panelists discuss how circulating tumor DNA (ctDNA) clearance rates during and after adjuvant chemotherapy (ACT) in the BESPOKE trial provide critical insights into treatment efficacy and may serve as...

As a nationally recognized provider of continuing education for healthcare professionals, CCS develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.

John L. Marshall, MD, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer.

Panelists discuss how circulating tumor DNA (ctDNA) serves as a promising biomarker for early detection, treatment monitoring, and recurrence surveillance in patients with colorectal cancer (CRC).

Panelists discuss how the BESPOKE study’s innovative design, carefully selected efficacy end points, and rigorous methodological approach aim to evaluate personalized therapeutic interventions with un...

John L. Marshall, MD, discusses the impact of the SUNLIGHT trial in patients with refractory metastatic colorectal cancer.

Half of all pancreatic-cancer patients live less than a year after diagnosis. But researchers say there is potential for change.

Dr Marshall highlights practice-changing research at ASCO GI, and discusses the turmoil caused by the new presidential administration’s abrupt policy changes.

The cheap painkiller seems to help the immune system detect and destroy cancers.

/PRNewswire/ -- A national survey conducted by MedStar Health to gauge the public's knowledge of screening guidelines for colorectal cancer, revealed 79% of...

Dr Marshall highlights practice-changing research at ASCO GI, and discusses the turmoil caused by the new presidential administration’s abrupt policy changes.